1-4 of 4
Lorena Fontan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL

Min Xia, Liron David, Matt Teater, Johana Gutierrez, Xiang Wang, Cem Meydan, Andrew Lytle, Graham W. Slack, David W. Scott, Ryan D. Morin, Ozlem Onder, Kojo S.J. Elenitoba-Johnson, Nahuel Zamponi, Leandro Cerchietti, Tianbao Lu, Ulrike Philippar, Lorena Fontan, Hao Wu, Ari M. Melnick
Journal: Cancer Discovery
Cancer Discov (2022) 12 (8): 1922–1941.
https://doi.org/10.1158/2159-8290.CD-21-1566
Published: 05 August 2022
View articletitled, BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL
Open the PDF for BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL in another window
Includes: Multimedia, Supplementary data
Journal Articles

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Patrizia Mondello, Saber Tadros, Matt Teater, Lorena Fontan, Aaron Y. Chang, Neeraj Jain, Haopeng Yang, Shailbala Singh, Hsia-Yuan Ying, Chi-Shuen Chu, Man Chun John Ma, Eneda Toska, Stefan Alig, Matthew Durant, Elisa de Stanchina, Sreejoyee Ghosh, Anja Mottok, Loretta Nastoupil, Sattva S. Neelapu, Oliver Weigert, Giorgio Inghirami, José Baselga, Anas Younes, Cassian Yee, Ahmet Dogan, David A. Scheinberg, Robert G. Roeder, Ari M. Melnick, Michael R. Green
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2020) 10 (3): 440–459.
https://doi.org/10.1158/2159-8290.CD-19-0116
Published: 03 March 2020
View articletitled, Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
Open the PDF for Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma in another window
Includes: Supplementary data
Journal Articles

TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis

Pilar M. Dominguez, Hussein Ghamlouch, Wojciech Rosikiewicz, Parveen Kumar, Wendy Béguelin, Lorena Fontán, Martín A. Rivas, Patrycja Pawlikowska, Marine Armand, Enguerran Mouly, Miguel Torres-Martin, Ashley S. Doane, María T. Calvo Fernandez, Matt Durant, Veronique Della-Valle, Matt Teater, Luisa Cimmino, Nathalie Droin, Saber Tadros, Samaneh Motanagh, Alan H. Shih, Mark A. Rubin, Wayne Tam, Iannis Aifantis, Ross L. Levine, Olivier Elemento, Giorgio Inghirami, Michael R. Green, Maria E. Figueroa, Olivier A. Bernard, Said Aoufouchi, Sheng Li, Rita Shaknovich, Ari M. Melnick
Journal: Cancer Discovery
Cancer Discov (2018) 8 (12): 1632–1653.
https://doi.org/10.1158/2159-8290.CD-18-0657
Published: 03 December 2018
View articletitled, TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis
Open the PDF for TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis in another window
Includes: Supplementary data
Journal Articles

Discovering What Makes STAT Signaling TYK in T-ALL

Lorena Fontan, Ari Melnick
Journal: Cancer Discovery
Cancer Discov (2013) 3 (5): 494–496.
https://doi.org/10.1158/2159-8290.CD-13-0123
Published: 08 May 2013
View articletitled, Discovering What Makes STAT Signaling TYK in T-ALL
Open the PDF for Discovering What Makes STAT Signaling TYK in T-ALL in another window